IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Chemie Uetikon acquires amino acid building blocks business in Switzerland from CordenPharma

4:05 AM MST | February 21, 2014 | Deepti Ramesh

Chemie Uetikon (Lahr, Germany) says that it acquired the entire business and product portfolio of amino acid building blocks from CordenPharma Switzerland, an active pharmaceutical ingredient (API) manufacturing facility at Liestal, Switzerland, effective 1 February. Chemie Uetikon is a chemical and pharmaceutical producer with expertise in manufacturing of generic and innovative APIs and a custom manufacturing business focused on the pharmaceutical industry. CordenPharma, which is the pharmaceutical brand of International Chemical Investors Group (ICIG), is a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa